USD 18.27 Billion
Colorectal Cancer Therapeutics Market Size, Share, Growth Analysis, By Drug Class(Chemotherapy, Immunotherapy, Others), By Cancer Type(Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35A2691 |
Region:
Global |
Published Date: October, 2024
Pages:
157
|Tables:
63
|Figures:
75
Colorectal Cancer Therapeutics Market Insights
Colorectal Cancer Therapeutics Market size was valued at USD 12.17 Billion in 2023 and is poised to grow from USD 12.77 Billion in 2024 to USD 18.71 Billion by 2032, growing at a CAGR of 4.9% during the forecast period (2025-2032).
Colorectal cancer therapeutics help in preventing the growth, spread, and recurrence of colorectal cancer cells and these can be administered through various modes. Furthermore, colorectal cancer therapeutics are generally utilized in combination to enhance the result of the treatment and address the complexity of the illness. Constant research and clinical trials are being conducted for exploring new and enhanced therapeutic options for colorectal cancer patients.
The therapeutics market for colorectal cancer consists of an extensive range of products that can manage, prevent, or cure any kind of cancer. These products consist of chemotherapy drugs, targeted therapies, and immunotherapies. These medications can reduce the development of cancer cells, induce apoptosis, or target pathways related to the progression of colorectal cancer. The increasing prevalence of colorectal cancer globally is one of the primary drivers for the market, requiring advancement and adoption of efficient therapeutic interventions. Moreover, the emergence of biosimilar for biologics drugs utilized in colorectal cancer treatment is also increasing competition and potentially minimizing treatment expenses, offering more cost-efficient alternatives.
US Colorectal Cancer Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Immunotherapy
Fastest Growth
Immunotherapy
Growth Rate
4% CAGR
Global Colorectal Cancer Therapeutics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Colorectal Cancer Therapeutics Market Segmental Analysis
Global Colorectal Cancer Therapeutics Market is segmented by Drug Class, Cancer Type, Distribution Channel, and region. Based on Drug Class, the market is segmented into Chemotherapy, Immunotherapy, and Others. Based on Cancer Type, the market is segmented into Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Drug Class
Based on drug class, chemotherapy segment is dominating the market with the largest colorectal cancer therapeutics market share. Chemotherapy is one of the main treatments for colorectal cancer and goes everywhere in the body to seek and kill these cancer cells. It is frequently used in the adjuvant, neoadjuvant, or palliative context of the disease process. Commonly used chemotherapeutic agents such as fluorouracil, oxaliplatin and irinotecan are utilized singly or in combination with targeted therapies to improve effectiveness. This segment is also being spurred by increasing applicability in terms of formulation innovations like drug delivery systems, such as liposomal formulations. This is further attributed to the increase in prevalence of colorectal cancer worldwide, and the growing preference for combination therapies. To overcome the issues like toxicity and resistance, many clinical trials are currently underway with novel combinations of drugs and based on patient variability.
The targeted therapy segment is witnessing the fastest growth in the colorectal cancer therapeutics market. Colorectal cancer therapeutics market is on the verge of transformation through targeted therapy, allowing precision-based treatment with less side effects and higher efficacy. Bevacizumab and cetuximab are examples of agents targeting VEGF and EGFR pathways, respectively, extensively used in the metastatic setting. Therapies targeting specific biomarkers, such as BRAF and MSI-high, which fall under the category of biomarker-based personalized medicine, are drawing increasing attention. This area is significantly supported by ongoing development in monoclonal antibodies and small molecule inhibitors segments. Increasing healthcare expenditure and prevalence of genomic profiling is also aiding in the adoption of targeted therapy. The growing investments in healthcare and escalating awareness of genetic profiling continue to drive adoption of targeted therapies. Although these treatments are expensive, their better results in improving mortality rates and quality of life are raising their demand in both developed and developing markets.
Analysis by Distribution Channel
Based on distribution channel, the hospital pharmacies segment is dominating the colorectal cancer therapeutics market. Therapeutics used for colorectal cancer are prominent in the hospital pharmacy channel because the hospital pharmacy setting ensures optimal delivery of these specialty and specialized treatments. The growth of this channel can be attributed to the rising prevalence of cancer treatment in hospital settings, along with developing infusion techniques. Moreover, hospitals act as major centers for clinical trials, which also increases the need for advanced therapeutics. Moreover, integrated care models are here to stay, meaning hospital pharmacies will continue to play a crucial role in the therapeutic supply chain. They are especially important for the administration of intravenous therapies such as chemotherapy and targeted therapy drugs, which must be administered under professional supervision.
As per colorectal cancer therapeutics market analysis, the online pharmacies segment is expected to witness the fastest growth during the forecast period. Growing preference for online pharmacies as a source for colorectal cancer therapeutics, which is cost-effective and accessible, is favoring the growth of the segment. Oral medicines like capecitabine and targeted therapies which can be delivered to home at discounted price, is increasing its popularity among patients and caregivers. The growth of this segment is attributed to increasing regulatory advancements and e-commerce penetration in healthcare. In addition, online websites enable access to patient assistance programs, refill reminders, and overall better adherence with medication.
To get detailed analysis on other segments, Request For Free Sample Report
Colorectal Cancer Therapeutics Market Regional Insights
North America is dominating with the largest colorectal cancer therapeutic market share. The colorectal cancer therapeutics market is highly dominated by North America owing to well established healthcare infrastructure and extensive research and development (R&D) investments. Increasing awareness campaigns is help in an early discovery of disease and treatment, which is benefitting the region. Significant market share is accounted by the United States due to its developed healthcare and pharmaceutical industry and a high rate of colorectal cancer. Easy reimbursement policies along with government backing bolster the market growth. The market is expanding due to ongoing clinical trials in drug development and new FDA approvals. But increased cost of treatment is an issue, as this may also impede some of the patient populations from accessing treatment.
The Asia-Pacific market is witnessing the fastest growth in the colorectal cancer therapeutics market. The rapid market growth of the Asia Pacific colorectal cancer therapeutics market can be attributed to the rising incidences of colorectal cancer and the upgradation of healthcare systems. Due to this China, India and Japan are the key contributors, supported with rising health awareness and better quality of care. A huge patient population as well as a growth in government programs regarding cancer management are anticipated to drive the growth of the market in this region. The advanced technology landscape poised Japan to lead in targeted and immunotherapy penetrations. On the other hand, China and India are witnessing the rise of attractive markets owing to the increasing healthcare infrastructure and growing healthcare expenditure.
Global Colorectal Cancer Therapeutics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Colorectal Cancer Therapeutics Market Dynamics
Colorectal Cancer Therapeutics Market Drivers
Growing Prevalence of Colorectal Cancer
-
The increase in incidence of colorectal cancer globally is one of the major factors for the growth of the therapeutics market. This is being mainly attributed to lifestyle changes, increasing population of elderly people, and switch to unhealthy food habits. It has increased the need for prompt treatments, and these are now driving investments in newer more advanced therapies.
Advancement in Targeted Therapies
-
Targeted therapies, like monoclonal antibodies and small molecule inhibitors, are rapidly changing the landscape of treatment for colorectal cancer. Compared to traditional chemotherapy, these therapies are associated with better efficacy and less toxicity. Investment in R&D is helping in developing targeted therapies, multiple such drugs have achieved regulatory approvability by biopharmaceutical companies. The growing adoption rate of sophisticated diagnostic technologies like liquid biopsies for early identification will act as a major facilitator augmenting the market growth of these therapies across the globe.
Colorectal Cancer Therapeutics Market Restraints
High Treatment Expense
-
High price of colorectal cancer drugs is still a big barrier particularly developing and underdeveloped countries. Immunotherapies and targeted therapies are expensive, limiting access to these treatments for lower-income populations. In developed markets, the financial burden of extended treatment regimens is a concern as the patient often is unwilling to complete therapies. Such economic adversities restrict the huge potential of growth in the market by providing the dire need of affordable requirements.
Strict Regulatory Approvals
-
Regulatory frameworks for drug approvals have remained stringent, restricting the market growth. The colorectal cancer necessitates rigorous clinical trials to confirm drug safety and efficacy before approval, which delays the availability of effective drugs to the patient population. This process is expensive and time-consuming, leading to a delay in getting effective treatments to patients. Moreover, different regulatory requirements in various regions make the path to commercialization more complex for biopharmaceutical companies.
Request Free Customization of this report to help us to meet your business objectives.
Colorectal Cancer Therapeutics Market Competitive Landscape
The global colorectal cancer therapeutics market is characterised by a competitive landscape with numerous players striving to develop and deliver effective treatments for colorectal cancer. The market features a mix of multinational pharmaceutical companies, biotechnology firms, and research institutions actively engaged in the research, development, and commercialization of colorectal cancer therapeutics. Competition in the market revolves around factors such as the efficacy of therapies, safety profiles, and the ability to target specific molecular pathways involved in colorectal cancer progression. Market players invest significantly in research and development activities to discover novel treatment approaches, develop innovative therapies, and conduct clinical trials to assess their efficacy. Strategic partnerships and collaborations are common in the market as companies seek to leverage each other's strengths and resources. Collaborations between pharmaceutical companies, research institutions, and academic centres help in sharing knowledge, accessing specialised expertise, and expediting the development of new therapeutic interventions.
Additionally, market players actively engage in acquiring or licensing promising drug candidates or technologies from smaller biotechnology companies or research institutions. These partnerships and acquisitions enable companies to expand their product portfolios and access new markets, thereby enhancing their competitive position. Marketing and promotional efforts are essential in the competitive landscape of the colorectal cancer therapeutics market. Companies engage in targeted marketing campaigns to raise awareness about their products among healthcare professionals, oncologists, and patients. Establishing strong brand recognition and reputation is crucial in capturing market share and gaining the trust of healthcare providers and patients.
Colorectal Cancer Therapeutics Market Top Player’s Company Profile
- Amgen, Inc. (US)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (US)
- Lilly (US)
- Merck & Co., Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Sanofi (France)
- Pfizer Inc. (US)
- Novartis AG (Switzerland)
- Regeneron Pharmaceuticals, Inc. (US)
- AstraZeneca PLC (UK)
- Gilead Sciences, Inc. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- Ipsen Pharma (France)
- Sumitomo Pharma Co., Ltd. (Japan)
- Exelixis, Inc. (US)
- BeiGene, Ltd. (China)
- Oncolytics Biotech Inc. (Canada)
- NantKwest, Inc. (US)
- Eisai Co., Ltd. (Japan)
- Incyte Corporation (US)
- MacroGenics, Inc. (US)
- Halozyme Therapeutics, Inc. (US)
Colorectal Cancer Therapeutics Market Recent Developments
- In November 2023, U.S. FDA (Food and Drug Administration) approved Takeda’s FRUZAQLA (fruquintinib), a novel oral targeted therapy for adults with metastatic colorectal cancer (mCRC). FRUZAQLA represents a non-chemotherapy treatment solution and offers meaningful survival assistance to patients without a significant impact on their quality of life, the company said.
- In August 2023, Taiho Pharmaceutical Co., Ltd. Taiho Oncology, Inc.has received U.S. Food and Drug Administration (FDA) approval of LONSURF (trifluridine/tipiracil), for the treatment of adult patients with metastatic colorectal cancer (mCRC) as a single agent or in combination with bevacizumab.
- In June 2023, Enzene Biosciences has introduced its more affordable version of Bevacizumab for metastatic colorectal cancer treatment. A biosimilar replacement for the pricey Avastin.
Colorectal Cancer Therapeutics Key Market Trends
- Increasing Adoption of Immunotherapy: Immunotherapy is turning out to be a ground-breaking treatment for colorectal cancer. Immune checkpoint inhibitors and cancer vaccines are gaining traction especially in patients with high microsatellite instability (MSI-H) tumors. Ongoing clinical trials and approvals of additional immunotherapy medications are consistent with this trend. Immunotherapy can also be combined with conventional chemotherapy, a strategy that is developing as the most effective approach, one that prolongs survival and improves quality of life.
- Expansion of Online Pharmacies: The emergence of internet portals for the distribution of colorectal cancer products. These platforms provide accessibility, affordability, and a large variety of medicines, which is a big reason for their growing popularity among patients. Moreover, collaborations of pharma firms with e-commerce platforms are assuring fast delivery of niche pharmaceutical drugs. The online pharmacy segment will witness high growth due to significant improvements in logistics and digital payment systems that will increase accessibility to important therapies across the world.
Colorectal Cancer Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the colorectal cancer therapeutics industry is witnessing a significant growth due to increasing development in drugs, rising awareness for the disease, and increasing incidences of colorectal cancer in the world. New therapies like targeted therapies, immunotherapies and combinations with chemotherapy have greatly improved patient results. Continuous R&D expenditure for personalized medicine is aiding the growth of the market. Furthermore, the increasing incidence and subsequently early diagnosis owing to the availability of better screening programs drives the growth of the market. The market for colorectal cancer therapeutics is expected to grow exponentially over the next several years as general healthcare infrastructures improve, particularly in emerging economies.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 11.6 billion |
| Market size value in 2031 | USD 17.84 billion |
| Growth Rate | 4.9% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Colorectal Cancer Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Colorectal Cancer Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Colorectal Cancer Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Colorectal Cancer Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Colorectal Cancer Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Colorectal Cancer Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
